1 Min Read
May 26 (Reuters) - Zomedica Pharmaceuticals Corp
* Zomedica pharmaceuticals corp announces first quarter 2016 financial results of Zomedica Pharmaceuticals Inc.
* Recorded net loss and comprehensive loss for three months ended March 31, 2016 of $931,642 or $0.01 per share.
* Expects research and development expenditures throughout 2016 will be higher as activities accelerate. Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)